Quality research. Outstanding publications. With an impact factor of 3.016 (2018), ChemMedChem is a top journal for research at the interface of chemistry, biology and medicine. ChemMedChem is made in Europe, but publishes primary as well as critical secondary and tertiary information from authors across and for the world. Its mission is to integrate the wide and flourishing field of medicinal and pharmaceutical sciences, ranging from drug design and discovery to drug development and delivery, from molecular modeling to combinatorial chemistry, from target validation to lead generation and ADMET studies. ChemMedChem typically covers topics on small molecules, therapeutic macromolecules, peptides, peptidomimetics, and aptamers, protein-drug conjugates, nucleic acid therapies, and beginning 2017, nanomedicine, particularly 1) targeted nanodelivery, 2) theranostic nanoparticles, and 3) nanodrugs.

Full Papers and Communications
Reviews and Minireviews
Patent Reviews
Highlights and Concepts
Book and Multimedia Reviews

Chairs
Karl-Heinz Altmann (ETH Zürich)
Sangyong Jon (KAIST)
Antonello Mai (Università degli Studi di Roma "La Sapienza")
Members
(Switzerland) Yves Auberson (Novartis Institute for BioMedical Research)
(Germany) Annette Beck-Sickinger (University of Leipzig)
(USA) Ashutosh Chilkoti (Duke University)
(USA) Paul J. Coleman (Merck Research Laboratories, West Point, PA)
(USA) Arun K. Ghosh (Purdue University, West Lafayette, IN)
(Spain) Jesús Jiménez Barbero (CIC bioGUNE: Center for Cooperative Research in Biosciences, Derio)
(Germany) Gerhard Klebe (Philipps-Universität Marburg)
(Italy) Filippo Minutolo (Università di Pisa)
(Italy) Marco Mor (Università degli Studi di Parma)
(China) Renxiao Wang (Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences)
(Australia) David A. Winkler (CSIRO, Clayton)
Internationa Advisory Board
(United Kingdom) Christopher Abell (University of Cambridge)
(Italy) Maria Camilla Bergonzi (University of Florence)
(Italy) Maria Laura Bolognesi (Università di Bologna)
(Italy) Maurizio Botta (Università degli Studi di Siena)
(Italy) Massimo Bottini (University of Rome Tor Vergata)
(United Kingdom) Nathan Brown (BenevolentAI, London)
(Spain)María José Camarasa (CSIC: Instituto de Química Médica, Madrid)
(China) Aoneng Cao (Shanghai University)
(Singapore) Christina Chai (National University of Singapore)
(India) Tushar K. Chakraborty (Indian Institute of Science, Bangalore)
(USA) Ravi Chari (ImmunoGen)
(Italy) Girolamo Cirrincione (Università degli Studi di Palermo)
(Germany) Bernd Clement (Christian-Albrechts-Universität Kiel)
(Sweden) Werngard Czechtizky (AstraZeneca)
(Spain) Angel R. de Lera (Universidad de Vigo)
(Italy) Carlo De Micheli (Università degli Studi di Milano)
(Switzerland) François Diederich (ETH Zürich)
(Switzerland) Beat Ernst (Universität Basel)
(USA) Omid Farokhzad (Brigham and Women's Hospital, Harvard Medical School)
(USA) Sylvie Garneau-Tsodikova (University of Kentucky)
(United Kingdom) Ian H. Gilbert (University of Dundee)
(France) Sylviane Giorgi-Renault (Université Paris Descartes)
(Spain) Ernest Giralt (Institute for Research in Biomedicine, Barcelona)
(Spain) Concepcion Gonzalez-Bello (Universidade de Santiago de Compostela)
(Austria) Ronald Gust (Universität Innsbruck)
(United Kingdom) Michael M. Hann (GlaxoSmithKline, Stevenage)
(Germany) Rolf W. Hartmann (Helmholtz Institute for Pharmaceutical Research Saarland)
(Germany) Ingo Hartung (Merck KGaA, Darmstadt)
(Czech Republic) Zlatko Janeba (Institute of Organic Chemistry and Biochemistry CAS)
(Australia) Michael Kassiou (The University of Sydney)
(Singapore) Thomas H. Keller (Experimental Therapeutics Centre, A*Star)
(South Korea) Gyochang Keum (Korea Institute of Science and Technology)
(USA) Karen Lackey (Medical University of South Carolina)
(Germany) Twan Lammers (RWTH Aachen University)
(USA) Craig W. Lindsley (Vanderbilt University, Nashville, TN)
(China) Zhuang Liu (Soochow University)
(China) Ya-Qiu Long (Soochow University)
(Germany) Rainer Metternich (Berlin)
(Italy) Stefano Moro (Università degli Studi di Padova)
(USA) Heinz E. Moser (Novartis )
(Switzerland) Klaus Mueller (ETH Zürich)
(France) Sylviane Muller (Institut de Biologie Moléculaire et Cellulaire, Strasbourg)
(Germany) Christa E. Müller (Universität Bonn)
(Germany) Peter Nussbaumer (Lead Discovery Center GmbH, Dortmund)
(United Kingdom) Paul O'Neill (University of Liverpool)
(Germany) Alleyn Plowright (Sanofi)
(Finland) Antti Poso (Itä-Suomen Yliopisto, Kuopio)
(UK) Barry V. L. Potter (University of Bath)
(Portugal) Maria M. M. Santos (University of Lisbon)
(Italy) Gianluca Sbardella (University of Salerno)
(United Kingdom) Sarah Skerratt (Vertex Pharmaceuticals)
(USA) Michael J. Sofia (Arbutus Biopharma)
(Switzerland) Martin Stahl (F. Hoffmann-La Roche Ltd)
(USA) Matthew Stanton (Generation Bio)
(Switzerland) Hans Ulrich Stilz (Novo Nordisk)
(Germany) Henning Steinhagen (Grünenthal GmbH, Aachen)
(France) Eva Toth (CNRS Orléans)
(Israel) Edit Tshuva (Hebrew University of Jerusalem)
(Belgium) Serge Van Calenbergh (Universiteit Gent)
(Germany) Klaus T. Wanner (Ludwig-Maximilians Universität München)
(Japan) Yasuyoshi Watanabe (RIKEN Center for Life Science Technologies (CLST))
(United Kingdom) Paul G. Wyatt (University of Dundee)